These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 21366040)
1. Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors. Mohammed HA; Ba LA; Burkholz T; Schumann E; Diesel B; Zapp J; Kiemer AK; Ries C; Hartmann RW; Hosny M; Jacob C Nat Prod Commun; 2011 Jan; 6(1):31-4. PubMed ID: 21366040 [TBL] [Abstract][Full Text] [Related]
2. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors. Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors. Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230 [TBL] [Abstract][Full Text] [Related]
4. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488 [TBL] [Abstract][Full Text] [Related]
5. Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols. Neves MA; Dinis TC; Colombo G; Sá e Melo ML ChemMedChem; 2007 Dec; 2(12):1750-62. PubMed ID: 17910019 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer. Maiti A; Cuendet M; Croy VL; Endringer DC; Pezzuto JM; Cushman M J Med Chem; 2007 Jun; 50(12):2799-806. PubMed ID: 17511439 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and inhibition of PGE2 production of 6,8-disubstituted chrysin derivatives. Park H; Dao TT; Kim HP Eur J Med Chem; 2005 Sep; 40(9):943-8. PubMed ID: 15963606 [TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study. van Meeuwen JA; Nijmeijer S; Mutarapat T; Ruchirawat S; de Jong PC; Piersma AH; van den Berg M Toxicol Appl Pharmacol; 2008 May; 228(3):269-76. PubMed ID: 18201740 [TBL] [Abstract][Full Text] [Related]
9. Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme. Gobbi S; Cavalli A; Rampa A; Belluti F; Piazzi L; Paluszcak A; Hartmann RW; Recanatini M; Bisi A J Med Chem; 2006 Jul; 49(15):4777-80. PubMed ID: 16854084 [TBL] [Abstract][Full Text] [Related]
10. 4- and 6-(p-Sulphamoylphenyl)androstenediones: Studies of aromatase inhibitor-based oestrone sulphatase inhibition. Watari Y; Yamaguchi S; Takahashi M; Nagaoka M; Numazawa M Steroids; 2010 Dec; 75(12):891-6. PubMed ID: 20546769 [TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors: structural features and biochemical characterization. Hong Y; Chen S Ann N Y Acad Sci; 2006 Nov; 1089():237-51. PubMed ID: 17261771 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones. Kim YW; Hackett JC; Brueggemeier RW J Med Chem; 2004 Jul; 47(16):4032-40. PubMed ID: 15267241 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents. Jindal DP; Bedi V; Jit B; Karkra N; Guleria S; Bansal R; Palusczak A; Hartmann RW Farmaco; 2005 Apr; 60(4):283-90. PubMed ID: 15848202 [TBL] [Abstract][Full Text] [Related]
14. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors. Neves MA; Dinis TC; Colombo G; Sá e Melo ML Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors. Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929 [TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibition by bioavailable methylated flavones. Ta N; Walle T J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):127-9. PubMed ID: 17624765 [TBL] [Abstract][Full Text] [Related]
18. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors. Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities. Bubert C; Woo LW; Sutcliffe OB; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV ChemMedChem; 2008 Nov; 3(11):1708-30. PubMed ID: 18816537 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents. Suresh Babu K; Hari Babu T; Srinivas PV; Hara Kishore K; Murthy US; Rao JM Bioorg Med Chem Lett; 2006 Jan; 16(1):221-4. PubMed ID: 16213726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]